AstraZeneca Plots Crucial IDO Phase III Combo Trial With Incyte Post author:Sam Post published:October 30, 2017 Post category:BioPharma Astra and Incyte are pushing forward on the development of immunotherapy combination treatments. Source: BioSpace You Might Also Like 3 Biotechs Bloodied Celgene Could Take Out October 30, 2017 Amazon Has Top Secret 1492 Unit Working on Healthcare and Telemedicine July 27, 2017 U.S. Department of Justice to Take on Opioid Manufacturers and Distributors February 28, 2018